Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer. [electronic resource]
Producer: 20130517Description: 352-9 p. digitalISSN:- 1532-6535
- Adiponectin -- metabolism
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- blood
- Dose-Response Relationship, Drug
- Edema -- blood
- Female
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemic Agents -- adverse effects
- Insulin Resistance
- Male
- Middle Aged
- Mitochondrial Proteins -- drug effects
- Pioglitazone
- Pyridines -- adverse effects
- Thiazolidinediones -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.